Tag results:

Publication

Centrosome Amplification and Aneuploidy Driven by the HIV-1-Induced Vpr•VprBP•Plk4 Complex in CD4+ T Cells

[Nature Communications] Investigators observed that approximately 1–5% of CD4+ T cells from the blood of people living with HIV-1 exhibited over-duplicated centrioles, suggesting that centrosome amplification underlies the development of HIV-1-associated cancers by driving aneuploidy.

Human Neutrophils Drive Skin Autoinflammation by Releasing Interleukin (IL)-26

[Journal Of Experimental Medicine] Scientists identified neutrophils as an important source of IL-26 and point to IL-26 as the key link between neutrophils and a self-sustaining autoinflammation loop in pustular psoriasis.

A Single-Agent Fusion of Human IL-2 and Anti-IL-2 Antibody That Selectively Expands Regulatory T Cells

[Communications Biology] Investigators discovered an anti-human IL-2 antibody and engineer a covalently-linked single-agent fusion of human IL-2 and its antibody that selectively expands Treg cells and exhibits superior disease control activity in animal models of ulcerative colitis and systemic lupus erythematosus, with proper safety profile and good developability.

Mi-2β Promotes Immune Evasion in Melanoma by Activating EZH2 Methylation

[Nature Communications] Scientists identified Mi-2β as a key melanoma-intrinsic effector regulating the adaptive anti-tumor immune response. Studies in genetically engineered mouse melanoma models indicated that loss of Mi-2β rescues the immune response to immunotherapy in vivo.

Impact of NDUFAF6 on Breast Cancer Prognosis: Linking Mitochondrial Regulation to Immune Response and PD-L1 Expression

[Cancer Cell International] Researchers explored the expression and functional significance of NDUFAF6 in breast cancer using various databases and experimental models.

T Cell Help in the Tumor Microenvironment Enhances Rituximab-Mediated NK Cell ADCC

[Blood] Investigators conducted studies using a novel mouse model and clinical correlative analysis to assess whether T cell help contributed to rituximab-mediated nature killer cell antibody-dependent cellular cytotoxicity in the tumor microenvironment in vivo.

Popular